Fig. 1
From: Interference with KCTD9 inhibits NK cell activation and ameliorates fulminant liver failure in mice
Elevated KCTD9 expression bothin liver tissue and hepatic NK cells in MHV-3-FHF mouse model. a KCTD9 expression in liver, heart, kidney, spleen, PBMC was determined in Balb/cJ mice with or without infection of 100 PUF of MHV3. b The expression of KCTD9 protein in liver and spleen 48 h after MHV-3 infection. Magnification: 400 X. c mKCTD9 mRNA levels in hepatic NK cell, CD4+ T cell, CD8+ T cell and hepatocyte isolated from Balb/cJ mice with or without MHV-3 infection. d The FACS assay showed that Percentage of hepatic CD4+ T cells and CD8+ T cells expressing KCTD9 in mice with or without MHV-3 infection for 24, 48, 72 and 96 h. *p < 0.05, **p < 0.01, Means ± SEM of 3 independent experiments were represented